Sealoflex Ultima EP1 Primer

SECTION 2: Hazards identification

Adverse physicochemical, human health and environmental effects

May produce an allergic reaction.

2.2 Label elements

Labelling

Supplemental label elements

EUH208 - Contains 2,4,7,9-Tetramethyl-5-decin-4,7-diol, reaction mass of 5-chloro-2- methyl-2H-isothiazol-3-one and 2-methyl-2H-isothiazol-3-one (3:1), 1,2-benzisothiazol- 3(2H)-one; 1,2-benzisothiazolin-3-one, [3-(2,3-epoxypropoxy)propyl]diethoxymethylsilane. May produce an allergic reaction. EUH210 - Safety data sheet available on request.

2.3 Other hazards

Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component 2,4,7,9-Tetramethyl-5-decin-4,7-diol (126-86-3) This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII reaction mass of 5-chloro-2-methyl-2H-isothiazol-3- This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII one and 2-methyl-2H-isothiazol-3-one (3:1) (55965- This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII 84-9) 1,2-benzisothiazol-3(2H)-one; 1,2-benzisothiazolin-3- This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII one (2634-33-5) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII [3-(2,3-epoxypropoxy)propyl]diethoxymethylsilane This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII (2897-60-1) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII 2-(2-butoxyethoxy)ethanol; diethylene glycol This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII monobutyl ether (112-34-5) This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component 2-(2-butoxyethoxy)ethanol; diethylene glycol The substance is not included in the list established in accordance with Article 59(1) of monobutyl ether(112-34-5) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 [3-(2,3- The substance is not included in the list established in accordance with Article 59(1) of epoxypropoxy)propyl]diethoxymethylsilane(2897-60-1) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 2,4,7,9-Tetramethyl-5-decin-4,7-diol(126-86-3) The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 1,2-benzisothiazol-3(2H)-one; 1,2-benzisothiazolin-3- The substance is not included in the list established in accordance with Article 59(1) of one(2634-33-5) REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 reaction mass of 5-chloro-2-methyl-2H-isothiazol-3- The substance is not included in the list established in accordance with Article 59(1) of one and 2-methyl-2H-isothiazol-3-one (3:1)(55965-84- REACH for having endocrine disrupting properties, or is not identified as having endocrine 9) disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605